There is also the stimulation of gut hormones, as GLP1, GIP, and food intake inhibition by SCFAs may represent a novel mechanism by which GM regulates the pathological progression of NAFLD to NASH [12]. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.